Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.
about
Staphylococcus aureus α-toxin: nearly a century of intrigueWill there ever be a universal Staphylococcus aureus vaccine?Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogensAntibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolatesTargeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin PairsIntramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology.Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectinPhagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus.Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.Adaptive Immunity Against Staphylococcus aureus.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.Comparative Exoproteomics and Host Inflammatory Response in Staphylococcus aureus Skin and Soft Tissue Infections, Bacteremia, and Subclinical Colonization.Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.Staphylococcus aureus Protein A Disrupts Immunity Mediated by Long-Lived Plasma Cells.An immunological assay for identification of potential biofilm-associated antigens of Staphylococcus aureus.The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAGProtection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.Diversity of Virulence Factors Associated with West Australian Methicillin-Sensitive Staphylococcus aureus Isolates of Human Origin.Relative distribution of virulence-associated factors among Australian bovine Staphylococcus aureus isolates: Potential relevance to development of an effective bovine mastitis vaccine.Perspectives on vaccination in adults.Potential targets for next generation anti-microbial glycoconjugate vaccines.Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases.
P2860
Q26823686-4B03D6FE-AA9E-482B-B519-1DC5B085EA17Q26824837-C13F0BD3-97C6-4F7C-93DF-5566C561515DQ30415823-A00A50A5-B566-4DB3-87E5-17F19CE11213Q34595644-EC91E1FA-9F35-485B-A8AF-40B1DB59EDBCQ35439724-8E85FA5E-5CA1-4A82-8887-55C55133C90AQ35772579-45280602-24D3-42B3-839E-DBFABB79AF20Q35919380-5BE72BD7-DB5C-433E-9737-CEE5AFF973F6Q36609408-9914A6FE-FA4C-4516-B604-6ABF9D327616Q37312140-FFCA5A74-4B23-4E7A-B123-8E0B09B47BC1Q38494482-7846E630-FBEA-47D9-A34A-6E4409C09D64Q38741540-6E3953A4-75D8-484D-955B-790D95842CBBQ38751767-5D5D1A79-1E8B-4554-9C64-7AFC0DF4A18FQ39093233-40F2DDE8-DBE8-4804-A677-F6BDDFC58C01Q40028798-32CECC86-B3EE-49F3-A5AD-1DB4FBA8089DQ40245675-179E91E2-53D8-4771-BCEA-BA0A420E3930Q40392346-9A0FFF91-78B7-434E-92ED-E8542DE50C9EQ40702476-DF0EE409-F956-47A4-8D0A-18CA0BEF1446Q40776497-3A81D1F3-A856-4E37-9E38-4D1B7556FFF0Q41117685-8D6E2E27-7984-4660-AACD-C74B49EEB63FQ42770328-C8BF7241-FC40-4290-8544-DD36045E8F82Q43226506-5F97B95A-E338-4335-BCC4-1F5ED92D6763Q43497830-E8FF586F-7924-4FC4-934A-95EB1E89310EQ53701548-AFFF5918-24B9-4A8D-B650-957E80163941Q53702468-E8003F4B-E72C-47A6-93B7-DF1C519D2014
P2860
Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Opsonic and protective propert ...... taphylococcus aureus antigens.
@ast
Opsonic and protective propert ...... taphylococcus aureus antigens.
@en
Opsonic and protective propert ...... taphylococcus aureus antigens.
@nl
type
label
Opsonic and protective propert ...... taphylococcus aureus antigens.
@ast
Opsonic and protective propert ...... taphylococcus aureus antigens.
@en
Opsonic and protective propert ...... taphylococcus aureus antigens.
@nl
prefLabel
Opsonic and protective propert ...... taphylococcus aureus antigens.
@ast
Opsonic and protective propert ...... taphylococcus aureus antigens.
@en
Opsonic and protective propert ...... taphylococcus aureus antigens.
@nl
P2093
P2860
P1433
P1476
Opsonic and protective propert ...... Staphylococcus aureus antigens
@en
P2093
Clarissa Pozzi
Katarzyna Wilk
Marina Gening
Nikolay Nifantiev
P2860
P304
P356
10.1371/JOURNAL.PONE.0046648
P407
P577
2012-10-15T00:00:00Z